Transfers of Health Data from the European Union to the United States in a Post-Schrems II World
Amy C. Pimentel
The European Data Protection Board and a number of data protection authorities in EU Member States have issued guidance on how to safeguard EU/US data transfers post-Schrems II. Read more.
Sovereign Wealth Fund Investment in the Global Healthcare Industry
Sovereign Wealth Funds (SWF) seek out investments that are resilient, conducive to their aims and objectives, and reasonably free from market volatility. The global healthcare industry is therefore an attractive market for SWF investment. Read more.
Impact Finance: Innovative Solutions to Target Global Health Issues
Carl J. Fleming
While the basic investment infrastructure needs to be developed, impact investment is becoming a stable and sustainable alternative for institutional investors and high-net-worth individuals. Private equity funding is well suited as a powerful vehicle to address signiﬁcant healthcare, social, and environmental issues. Read more.
IP Ownership Considerations in Multi-jurisdictional Software Development Agreements
Edward A. Gordon
Cecilia Choy, Ph.D.
The use of overseas contractors to develop software applications may be cost-effective, but is potentially risky from the point of intellectual property rights. Read more.
COVID-19 Vaccination: Five Key Considerations for Healthcare Employers
Carole A. Spink
The question of whether or not to make vaccinations mandatory for workers is being considered by employers globally, particularly those in the healthcare sector. There are a number of key considerations that should be taken into account. Read more.
Access to Digital Health Applications and Digital Care Applications in Germany
Dr. Stephan Rau
| Dr. Karolin Hiller, McDermott Alumna
On 20 January 2021, the German Federal Cabinet approved the draft law on the digital modernisation of healthcare and nursing care. The draft has been criticised for not taking into account lessons learned from the implementation of the 2019 digital health applications law. Read more.
Paris Court of Appeals Rejects Pharmaceutical Supplementary Protection Certificate Applications
The Paris Court of Appeals has applied the recent Court of Justice of the European Union judgement in Royalty Pharma to confirm the French patent office’s rejection of three Supplemental Protection Certificate applications. Read more.